한글목차

일본뇌염 백신의 동향과 전망

세계 일본뇌염 백신 시장은 2024년부터 2030년까지 5.8%의 연평균 복합 성장률(CAGR)로 성장을 지속하여 2030년까지 약 3억 달러에 달할 것으로 예상됩니다. 이 시장의 주요 촉진요인은 일본뇌염 환자 증가, 경구약 수요 증가, 도시화로 인한 일본뇌염 노출 위험 증가입니다. 세계 일본뇌염 백신 시장의 미래는 병원, 소매 및 온라인 시장에서 기회가 있어 유망합니다.

일본뇌염 백신 시장 인사이트

Lucintel의 예측에 따르면, 약독성 생백신은 그 효과와 신체에 대한 강력한 면역 반응 유도로 인해 계속해서 가장 큰 부문이 될 것으로 예상됩니다.

이 시장에서 병원은 예측 기간 동안 가장 높은 성장률을 보일 것으로 예상됩니다.

인도, 중국, 일본에서는 일본뇌염의 위험이 증가함에 따라 APAC은 계속해서 가장 규모가 큰 지역이 될 것입니다.

이 보고서는 다음과 같은 11가지 주요 질문에 대한 답변을 담고 있습니다.

• Q.1. 시장 부문 중 가장 유망하고 성장성이 높은 기회는 무엇인가?
• Q.2. 어떤 부문이 더 빠른 속도로 성장할 것이며, 그 이유는 무엇인가?
• Q.3. 향후 성장이 가속화될 것으로 예상되는 지역과 그 이유는?
• Q.4. 시장 역학에 영향을 미치는 주요 요인은? 시장의 주요 과제와 비즈니스 리스크는 무엇인가?
• Q.5. 이 시장에서의 비즈니스 리스크와 경쟁 위협은 무엇인가?
• Q.6. 이 시장의 새로운 트렌드와 그 이유는?
• Q.7. 시장에서의 고객 수요 변화에는 어떤 것들이 있는가?
• Q.8. 이 시장의 새로운 발전과 그 발전을 주도하고 있는 기업은?
• Q.9. 이 시장의 주요 기업은? 주요 기업들은 사업 성장을 위해 어떤 전략적 노력을 기울이고 있는가?
• Q.10. 이 시장의 경쟁 제품에는 어떤 것들이 있으며, 소재 및 제품 대체에 따른 시장 점유율 하락의 위협은 어느 정도인가?
• Q.11. 지난 5년간 어떤 M&A가 이루어졌고, 업계에 어떤 영향을 미쳤는가?

목차

제1장 주요 요약

제2장 세계의 일본뇌염 백신 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 업계 촉진요인과 과제

제3장 시장 동향 및 예측 분석(2018-2030년)

• 거시경제 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 일본뇌염 백신 시장 동향(2018-2023년)과 예측(2024-2030년)
• 유형별 : 세계의 일본뇌염 백신 시장
  • 불활성화
  • 재조합
  • 약독성
• 유통 채널별 : 세계의 일본뇌염 백신 시장
  • 병원
  • 소매
  • 온라인
• 용도별 : 세계의 일본뇌염 백신 시장
  • 소아용 백신
  • 성인용 백신

제4장 지역별 시장 동향 및 예측 분석(2018-2030년)

• 지역별 세계의 일본뇌염 백신 시장
• 북미의 일본뇌염 백신 시장
• 유럽의 일본뇌염 백신 시장
• 아시아태평양의 일본뇌염 백신 시장
• 기타 지역의 일본뇌염 백신 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영상 통합
• Porter의 Five Forces 분석

제6장 성장 기회와 전략적 분석

• 성장 기회 분석
  • 유형별 세계의 일본뇌염 백신 시장 성장 기회
  • 유통 채널별 세계의 일본뇌염 백신 시장 성장 기회
  • 용도별 세계의 일본뇌염 백신 시장 성장 기회
  • 지역별 세계의 일본뇌염 백신 시장 성장 기회
• 세계 일본뇌염 백신 시장의 새로운 동향
• 전략적 분석
  • 신제품 개발
  • 세계의 일본뇌염 백신 시장 능력 확대
  • 세계의 일본뇌염 백신 시장의 인수합병(M&A) 및 합작투자(JV)
  • 인증 및 라이선싱

제7장 유력 기업의 기업 개요

• Valneva
• Sanofi
• Bharat Biotech International
• Chengdu Institute of Biological Products
• Adimmune

영문목차

Japanese Encephalitis Vaccine Trends and Forecast

The future of the global japanese encephalitis vaccine market looks promising with opportunities in the hospital, retail, and online markets. The global japanese encephalitis vaccine market is expected to reach an estimated $0.3 billion by 2030 with a CAGR of 5.8% from 2024 to 2030. The major drivers for this market are growing cases of japanese encephalitis, increasing demand for oral drugs, and irising risk of exposure to japanese encephalitis given to urbanization.

A more than 150-page report is developed to help in your business decisions.

Japanese Encephalitis Vaccine by Segment

The study includes a forecast for the global japanese encephalitis vaccine by type, distribution channel, application, and region.

Japanese Encephalitis Vaccine Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Inactivated
• Recombinant
• Live Attenuated

Japanese Encephalitis Vaccine Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals
• Retail
• Online

Japanese Encephalitis Vaccine Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Pediatric Vaccines
• Adult Vaccines

Japanese Encephalitis Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Japanese Encephalitis Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies japanese encephalitis vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the japanese encephalitis vaccine companies profiled in this report include-

• Valneva
• Sanofi
• Bharat Biotech International
• Chengdu Institute of Biological Products
• Adimmune

Japanese Encephalitis Vaccine Market Insights

Lucintel forecasts that live attenuated will remain the largest segment due to its effectiveness and inducing a strong immune response to the body.

Within this market, hospital is expected to witness highest growth over the forecast period.

APAC will remain the largest regiondue to rising risk of japanese encephalitis in India, China, and Japan.

Features of the Global Japanese Encephalitis Vaccine Market

Market Size Estimates: Japanese encephalitis vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Japanese encephalitis vaccine market size by type, distribution channel, application, and region in terms of value ($B).

Regional Analysis: Japanese encephalitis vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, distribution channels, applications, and regions for the japanese encephalitis vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the japanese encephalitis vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the japanese encephalitis vaccine market size?

Answer: The global japanese encephalitis vaccine market is expected to reach an estimated $0.3 billion by 2030.

Q.2 What is the growth forecast for japanese encephalitis vaccine market?

Answer: The global japanese encephalitis vaccine market is expected to grow with a CAGR of 5.8% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the japanese encephalitis vaccine market?

Answer: The major drivers for this market are growing cases of japanese encephalitis, increasing demand for oral drugs and irising risk of exposure to japanese encephalitis given to urbanization.

Q4. What are the major segments for japanese encephalitis vaccine market?

Answer: The future of the japanese encephalitis vaccine market looks promising with opportunities in the hospital, retail, and online markets.

Q5. Who are the key japanese encephalitis vaccine market companies?

Answer: Some of the key japanese encephalitis vaccine companies are as follows:

• Valneva
• Sanofi
• Bharat Biotech International
• Chengdu Institute of Biological Products
• Adimmune

Q6. Which japanese encephalitis vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that live attenuated will remain the largest segment due to its effectiveness and inducing a strong immune response to the body.

Q7. In japanese encephalitis vaccine market, which region is expected to be the largest in next 5 years?

Answer: APAC will remain the largest regiondue to rising risk of japanese encephalitis in India, China, and Japan.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the japanese encephalitis vaccine market by type (inactivated, recombinant, and live attenuated), distribution channel (hospitals, retail, and online), application (pediatric vaccines and adult vaccines), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Japanese Encephalitis Vaccine Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Japanese Encephalitis Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Japanese Encephalitis Vaccine Market by Type
  • 3.3.1: Inactivated
  • 3.3.2: Recombinant
  • 3.3.3: Live Attenuated
• 3.4: Global Japanese Encephalitis Vaccine Market by Distribution Channel
  • 3.4.1: Hospitals
  • 3.4.2: Retail
  • 3.4.3: Online
• 3.5: Global Japanese Encephalitis Vaccine Market by Application
  • 3.5.1: Pediatric Vaccines
  • 3.5.2: Adult Vaccines

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Japanese Encephalitis Vaccine Market by Region
• 4.2: North American Japanese Encephalitis Vaccine Market
  • 4.2.2: North American Japanese Encephalitis Vaccine Market by Distribution Channel: Hospitals, Retail, and Online
• 4.3: European Japanese Encephalitis Vaccine Market
  • 4.3.1: European Japanese Encephalitis Vaccine Market by Type: Inactivated, Recombinant, and Live Attenuated
  • 4.3.2: European Japanese Encephalitis Vaccine Market by Distribution Channel: Hospitals, Retail, and Online
• 4.4: APAC Japanese Encephalitis Vaccine Market
  • 4.4.1: APAC Japanese Encephalitis Vaccine Market by Type: Inactivated, Recombinant, and Live Attenuated
  • 4.4.2: APAC Japanese Encephalitis Vaccine Market by Distribution Channel: Hospitals, Retail, and Online
• 4.5: ROW Japanese Encephalitis Vaccine Market
  • 4.5.1: ROW Japanese Encephalitis Vaccine Market by Type: Inactivated, Recombinant, and Live Attenuated
  • 4.5.2: ROW Japanese Encephalitis Vaccine Market by Distribution Channel: Hospitals, Retail, and Online

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Japanese Encephalitis Vaccine Market by Type
  • 6.1.2: Growth Opportunities for the Global Japanese Encephalitis Vaccine Market by Distribution Channel
  • 6.1.3: Growth Opportunities for the Global Japanese Encephalitis Vaccine Market by Application
  • 6.1.4: Growth Opportunities for the Global Japanese Encephalitis Vaccine Market by Region
• 6.2: Emerging Trends in the Global Japanese Encephalitis Vaccine Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Japanese Encephalitis Vaccine Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Japanese Encephalitis Vaccine Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Valneva
• 7.2: Sanofi
• 7.3: Bharat Biotech International
• 7.4: Chengdu Institute of Biological Products
• 7.5: Adimmune